Subtopic Deep Dive

NF-κB in Inflammatory Diseases
Research Guide

What is NF-κB in Inflammatory Diseases?

NF-κB in Inflammatory Diseases examines the transcription factor NF-κB's central role in driving chronic inflammation through canonical and non-canonical pathways activated by TLR signaling and TNF-α in conditions like arthritis, atherosclerosis, and autoimmunity.

NF-κB regulates proinflammatory gene expression in response to stimuli like LPS, linking innate immunity to pathologies including rheumatoid arthritis and atherogenesis (Hayden and Ghosh, 2012; 1636 citations). Over 10 key papers from 2005-2021, with 1898 citations for Yu et al. (2020) on therapeutic targeting, detail inhibition strategies via A20 and other regulators. These studies highlight NF-κB's dual role in homeostasis and disease progression (Park and Hong, 2016; 606 citations).

Curated Papers

Key Challenges

Why It Matters

NF-κB drives macrophage foam cell accumulation and chemokine production in atherosclerosis, making it a target for vascular inflammation therapies (de Winther et al., 2005; 558 citations). In epithelial tissues, NF-κB dysregulation causes chronic gut inflammation, with A20 knockout mice exhibiting lethal autoimmunity, underscoring therapeutic potential (Shembade et al., 2010; 653 citations; Wullaert et al., 2010; 495 citations). Clinical studies target NF-κB for arthritis and cancer-linked inflammation, as reviewed by Yu et al. (2020; 1898 citations) and Park and Hong (2016; 606 citations), impacting drug development for 50+ million arthritis patients worldwide.

Key Research Challenges

Cell-Type Specific Inhibition

NF-κB functions differ across macrophages, endothelial cells, and epithelial cells, complicating broad inhibitors that risk immunosuppression (Mußbacher et al., 2019; 558 citations). Therapies must target vascular thrombosis links without disrupting homeostasis (de Winther et al., 2005). A20 disruption studies show ubiquitin complex specificity challenges (Shembade et al., 2010).

Transient vs Chronic Activation

Canonical NF-κB provides quick responses but sustains chronic inflammation in diseases like arthritis (Hayden and Ghosh, 2012; 1636 citations). Profiling LPS-induced responses reveals persistent proinflammatory genes in macrophages (Sharif et al., 2007; 486 citations). Balancing regulation remains unsolved (Yu et al., 2020).

Therapeutic Translation Barriers

Despite preclinical success, NF-κB inhibitors face toxicity in clinical trials for inflammatory diseases (Park and Hong, 2016; 606 citations). Non-canonical pathway targeting lacks robust human data (Zhang et al., 2021; 463 citations). Inflammation-thrombosis overlaps demand integrated models (Mußbacher et al., 2019).

Essential Papers

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study

Hui Yu, Liangbin Lin, Zhiqiang Zhang et al. · 2020 · Signal Transduction and Targeted Therapy · 1.9K citations

Abstract NF-κB pathway consists of canonical and non-canonical pathways. The canonical NF-κB is activated by various stimuli, transducing a quick but transient transcriptional activity, to regulate...

NF-κB, the first quarter-century: remarkable progress and outstanding questions

Matthew S. Hayden, Sankar Ghosh · 2012 · Genes & Development · 1.6K citations

The ability to sense and adjust to the environment is crucial to life. For multicellular organisms, the ability to respond to external changes is essential not only for survival but also for normal...

Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes

Noula Shembade, Averil Ma, Edward W. Harhaj · 2010 · Science · 653 citations

Limiting Inflammatory Signaling Dysregulation of the transcription factor NF-κB causes chronic inflammation, autoimmunity, and malignancy. The zinc-finger protein, A20, is vital for regulating NF-κ...

Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches

Mi Park, Jin Tae Hong · 2016 · Cells · 606 citations

Nuclear factor-κB (NF-κB) is a transcription factor that plays a crucial role in various biological processes, including immune response, inflammation, cell growth and survival, and development. NF...

Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis

Marion Mußbacher, Manuel Salzmann, Christine Brostjan et al. · 2019 · Frontiers in Immunology · 558 citations

The transcription factor NF-κB is a central mediator of inflammation with multiple links to thrombotic processes. In this review, we focus on the role of NF-κB signaling in cell types within the va...

Nuclear Factor κB Signaling in Atherogenesis

Menno P.J. de Winther, Edwin Kanters, Georg Kraal et al. · 2005 · Arteriosclerosis Thrombosis and Vascular Biology · 558 citations

Atherosclerosis is an inflammatory disease, characterized by the accumulation of macrophage-derived foam cells in the vessel wall and accompanied by the production of a wide range of chemokines, cy...

NF-κB in the regulation of epithelial homeostasis and inflammation

Andy Wullaert, Marion Bonnet, Manolis Pasparakis · 2010 · Cell Research · 495 citations

Reading Guide

Foundational Papers

Start with Hayden and Ghosh (2012; 1636 citations) for NF-κB history and activation overview, then Shembade et al. (2010; 653 citations) for A20 inhibition mechanisms, and de Winther et al. (2005; 558 citations) for atherogenesis applications to build inflammation context.

Recent Advances

Study Yu et al. (2020; 1898 citations) for therapy mechanisms, Mußbacher et al. (2019; 558 citations) for thrombosis links, and Zhang et al. (2021; 463 citations) for cancer-inflammation overlaps.

Core Methods

Core techniques: transcriptional profiling (Sharif et al., 2007), ubiquitin enzyme complex assays (Shembade et al., 2010), cell-type knockout models (Wullaert et al., 2010), and pathway inhibition screens (Yu et al., 2020).

How PapersFlow Helps You Research NF-κB in Inflammatory Diseases

Discover & Search

PapersFlow's Research Agent uses searchPapers and citationGraph on 'NF-κB inflammatory diseases' to map 250M+ OpenAlex papers, surfacing Yu et al. (2020; 1898 citations) as top-cited via exaSearch for therapy mechanisms, then findSimilarPapers reveals Park and Hong (2016) on arthritis applications.

Analyze & Verify

Analysis Agent applies readPaperContent to extract A20 ubiquitin mechanisms from Shembade et al. (2010), verifies claims with CoVe against Hayden and Ghosh (2012), and runs PythonAnalysis on Sharif et al. (2007) LPS profiling data for statistical NF-κB target gene clustering, graded via GRADE for evidence strength in macrophage inflammation.

Synthesize & Write

Synthesis Agent detects gaps in cell-type specificity from Mußbacher et al. (2019) vs. de Winther et al. (2005), flags contradictions in chronic activation models, while Writing Agent uses latexEditText, latexSyncCitations for Yu et al. (2020), and latexCompile to generate review sections with exportMermaid diagrams of NF-κB-TLR pathways.

Use Cases

"Analyze LPS-induced NF-κB gene expression data from macrophage studies for arthritis drug targets."

Research Agent → searchPapers('LPS NF-κB macrophages') → Analysis Agent → readPaperContent(Sharif et al., 2007) → runPythonAnalysis(pandas clustering on transcriptional profiles) → outputs ranked proinflammatory gene targets with statistical p-values.

"Draft LaTeX review on NF-κB inhibitors for atherosclerosis inflammation."

Synthesis Agent → gap detection(citationGraph de Winther 2005 + Yu 2020) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(10 papers) → latexCompile → outputs polished PDF with figure captions on atherogenesis pathways.

"Find GitHub code for NF-κB signaling simulations in inflammatory models."

Research Agent → searchPapers('NF-κB simulation inflammation') → Code Discovery → paperExtractUrls(Hayden 2012) → paperFindGithubRepo → githubRepoInspect → outputs verified Python models for canonical/non-canonical pathway dynamics.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ NF-κB inflammation papers via searchPapers → citationGraph → DeepScan 7-step analysis with CoVe checkpoints on Yu et al. (2020) claims. Theorizer generates hypotheses on A20-targeted therapies from Shembade et al. (2010) + Mußbacher et al. (2019), outputting mermaid diagrams of thrombosis links.

Try Doxa for NF-κB in Inflammatory Diseases Research

Frequently Asked Questions

What defines NF-κB's role in inflammatory diseases?

NF-κB drives proinflammatory gene expression via canonical pathways activated by TNF-α and TLRs in arthritis and atherosclerosis (Hayden and Ghosh, 2012; Yu et al., 2020).

What are key methods for studying NF-κB inhibition?

Methods include A20-mediated ubiquitin disruption (Shembade et al., 2010), transcriptional profiling of LPS responses (Sharif et al., 2007), and cell-type models for vascular inflammation (Mußbacher et al., 2019).

What are the most cited papers?

Yu et al. (2020; 1898 citations) on therapies, Hayden and Ghosh (2012; 1636 citations) on progress, Shembade et al. (2010; 653 citations) on A20 regulation.

What open problems exist?

Challenges include cell-specific inhibitors without toxicity, translating non-canonical targeting to clinics, and modeling chronic vs. transient activation (Park and Hong, 2016; Zhang et al., 2021).